Please Wait.....
Report
U.S. Laboratory Developed Tests (LDTs) Market - Focused Insights 2024-2029
Market Report I 2024-05-16 I 66 Pages I Arizton Advisory & Intelligence
The U.S. laboratory-developed tests (LDTs) market is expected to grow at a CAGR of 3.40% from 2023-2029.
MARKET TRENDS
Increase In Chronic and Infectious Diseases: The burden of infectious diseases and chronic disorders is constantly growing in the U.S. and worldwide. In the U.S., 45% of Americans suffer from at least one chronic disease, and this number is likely to grow. And 17% of the population in the U.S. is aged 65 and above. Chronic disorders include different types of cancers, diabetes, cardiovascular disorders, and others. Infectious diseases such as diphtheria, Ebola, flu, HIV/AIDS, etc, and outbreaks such as the virus COVID-19 which is consistently impacting the growth of the infectious disease testing market. The LDTs market has great potential to obstruct the path of rising disease incidences by early diagnosis and treatment monitoring based on diagnostics.
Increasing Product Offerings Related To Genetic Health Risks: Manufacturers of laboratory-developed tests across the U.S. will have plenty of lucrative offers in the coming years. Vendors have begun recognizing the value of R&D spending in providing a diversified product line. For instance, 23andMe and Virgin Groups merged to become a publicly traded company that will transform personalized healthcare and therapeutic advancements using human genetics. Many companies are taking extensive measures to make their product offerings more versatile through innovations, such as providing data on genetic health risks, traits, and ancestry.
The U.S. LABORATORY DEVELOPED TESTS MARKET INSIGHTS
- The molecular diagnostics test type segment is growing significantly, with the fastest-growing CAGR of 3.89% during the forecast period in the U.S. laboratory-developed tests (LDTs) market. Favorable reimbursement policies coupled with rising government support in funding and initiatives to develop diagnostics tests are anticipated to drive the U.S. molecular diagnostics growth.
- By application, the oncology segment dominated the market, occupying over 39% of the U.S. laboratory-developed tests (LDTs) market in 2023. The segmental growth can be attributed to the increasing prevalence of cancer diseases and high expenditures on healthcare.
- LDTs are not FDA-approved for marketing. Some of the reagents, controls, and equipment used in these tests may be manufactured (and are FDA-approved). The reagents in these instances are called Analyte Specific Reagents, or ASRs. In addition, some tests are developed as proprietary tests. The test is marketed to other labs and healthcare providers as a service, and samples must be sent to the lab that developed the test for analysis.
- Laboratories must constantly monitor the tests and test systems to ensure that the results generated remain as accurate, precise, sensitive, and specific as those initially validated. Federal and state governments and laboratory accrediting organizations also regulate these processes and examine them regularly.
VENDOR LANDSCAPE
The U.S. laboratory developed tests (LDTs) market report contains exclusive data on 27 vendors. The laboratory developed test (LDT) sector is experiencing a notable uptick in investment and innovation. This surge can be attributed to the growing precision and effectiveness of LDTs in detecting and diagnosing various diseases. Some independent laboratories, such as LabCorp and Quest Diagnostics, operate as two significant independents across the United States. These independent laboratories are domestic market players and hold a higher market share. Apart from that, several international independent clinical laboratories are present nationwide and compete with domestic small and mid-sized vendors. In the current landscape, high competition in the U.S. clinical laboratory tests market exists among LabCorp, Quest Diagnostics, Sonic Healthcare, and OPKO Health.
REPORT HIGHLIGHTS
SEGMENTATION & FORECAST
- By Test
- Clinical & Immunochemistry
- Molecular Diagnostics
- Microbiology
- Others
- By Application
- Oncology
- Rare & Genetic Disorders
- Autoimmune Disorders
- Infectious Diseases
- Others
VENDORS LIST
- LabCorp
- Eurofins
- Mayo Clinic
- OPKO Health Inc
- Quest Diagnostics
- Siemens Healthineers
- Sonic Healthcare
- Accu Reference Medical Lab
- ARUP Laboratories
- Clinical Reference Laboratory
- DaVita
- Empire City Laboratories
- Fresenius Medical Care
- Laboratory of Florida LLC
- HealthTrackRx
- Millennium Health
- U.S. Specialty Labs
- NeoGenomics
- Charles River Laboratories
- Centers Laboratory
- Qiagen
- Fuller Laboratories
- Unilab Corp
- Bionano Laboratories
- Cooper Clinics
- U.R. Medicine Laboratories
- Vista Clinical Laboratory
KEY QUESTIONS ANSWERED:
1. How big is the U.S. laboratory developed tests market?
2. What is the growth rate of the U.S. laboratory developed tests market?
3. What are the key trends in the U.S. laboratory developed tests (LDTs) market?
CHAPTER - 1: Laboratory Developed Tests Market Overview
- Executive Summary
- Key Findings
CHAPTER - 2: Laboratory Developed Tests Market
- US: Projected Revenue of Laboratory Developed Tests Market (2020-2029; $Billions)
CHAPTER - 3: Laboratory Developed Tests Market Segmentation Data
- US: Projected Revenue by Test Type (2020-2029; $Billions)
- Clinical & Immunochemistry
- Molecular Diagnostics
- Microbiology
- Others
- U.S.: Projected Revenue by Application (2020-2029; $Billions)
- Oncology
- Rare & Genetic Disorders
- Autoimmune Disorders
- Infectious Diseases
- Others
CHAPTER - 4: Laboratory Developed Tests Market Prospects & Opportunities
- Laboratory Developed Tests Market Opportunities & Trends
- Laboratory Developed Tests Market Drivers
- Laboratory Developed Tests Market Constraints
CHAPTER - 5: Laboratory Developed Tests Industry Overview
- Laboratory Developed Tests Market - Competitive Landscape
- Laboratory Developed Tests Market - Key Vendor Profiles
- Laboratory Developed Tests Market - Other Prominent Vendors
- Laboratory Developed Tests Market - Key Strategic Recommendations
CHAPTER - 6: Appendix
- Research Methodology
- Abbreviations
- About Arizton
LIST OF EXHIBITS
Exhibit 1: Projected Revenue of LDTs in the U.S. (2020-2029; $ Bn)
Exhibit 2: Market Size & Forecast - Clinical & Immunochemistry (2020-2029; $ Bn)
Exhibit 3: Market Size & Forecast - Molecular Diagnostics (2020-2029; $ Bn)
Exhibit 4: Market Size & Forecast - Microbiology (2020-2029; $ Bn)
Exhibit 5: Market Size & Forecast - Others (2020-2029; $ Bn)
Exhibit 6: Market Size & Forecast - Oncology (2020-2029; $ Bn)
Exhibit 7: Market Size & Forecast - Rare & Genetic Disorders ($ Bn)
Exhibit 8: Market Size & Forecast - Autoimmune Disorders (2020-2029; $ Bn)
Exhibit 9: Market Size & Forecast - Infectious Diseases (2020-2029; $ Bn)
Exhibit 10: Market Size & Forecast - Others (2020-2029; $ Bn)
LIST OF EXHIBITS
Exhibit 1: Projected Revenue of LDTs in the U.S. (2020-2029; $ Bn)
Exhibit 2: Market Size & Forecast - Clinical & Immunochemistry (2020-2029; $ Bn)
Exhibit 3: Market Size & Forecast - Molecular Diagnostics (2020-2029; $ Bn)
Exhibit 4: Market Size & Forecast - Microbiology (2020-2029; $ Bn)
Exhibit 5: Market Size & Forecast - Others (2020-2029; $ Bn)
Exhibit 6: Market Size & Forecast - Oncology (2020-2029; $ Bn)
Exhibit 7: Market Size & Forecast - Rare & Genetic Disorders ($ Bn)
Exhibit 8: Market Size & Forecast - Autoimmune Disorders (2020-2029; $ Bn)
Exhibit 9: Market Size & Forecast - Infectious Diseases (2020-2029; $ Bn)
Exhibit 10: Market Size & Forecast - Others (2020-2029; $ Bn)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security